A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate

By Vassiliou Vassilios   Kalogeropoulou Christine   Giannopoulou Efstathia   Leotsinidis Michael   Tsota Irine   Kardamakis Dimitrios  

Clinical and Experimental Metastasis, Vol. 24, Iss. 3, 2007-05 ,pp. : 169-178

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 713-720

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone metastases-The clinical problem

By Rubens R.D.  

European Journal of Cancer, Vol. 34, Iss. 2, 1998-02 ,pp. : 210-213

Elsevier

Access to resources Recommend Favorite

Randomized, open label, prospective study on the effect of zoledronic acid on the prevention of bone metastases in patients with recurrent solid tumors that did not present with bone metastases at baseline

By Mystakidou Kyriaki   Katsouda Emmanuela   Parpa Efi   Kelekis Alexis   Galanos Antonis   Vlahos Lambros  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 195-201

Humana Press, Inc

Access to resources Recommend Favorite

Disease Progression Increases the Risk of Skeletal-Related Events in Patients With Bone Metastases From Castration-Resistant Prostate Cancer, Lung Cancer, or Other Solid Tumors

By Simon Tchekmedyian N.   Chen Yin-Miao   Saad Fred  

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 849-855

Informa Healthcare

Access to resources Recommend Favorite